Pretargeting methods and compounds

Details Pretargeting methods and compounds Pretargeting methods and compounds

1994-08-26

1999-06-22

Eisenschenk, Frank C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514387, 530363, 530367, 530350, 530395, 530394, 568852, 536112, 5483037, C07K 14435, C07K 1447, C07D25702

Patent

active

059143126

ABSTRACT:
Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin and for improved radiohalogenation of biotin, as well as related compounds, are described. Also, clearing agents, anti-ligand-targeting moiety conjugates, target cell retention enhancing moieties and additional methods are discussed.

REFERENCES:
patent: 4863713 (1989-09-01), Goodwin et al.
Sharkey, R.M. et al., Radiobiology/Radiation Oncology #4192, American Association for Cancer Research, vol. 37, Mar. 1996, p. 611.
Robert W. Thornburg et al., Carbohydrate-mediated Clearance of Immune Complexes from the Circulation--A Role for Galactose Residues in the Hepatic Uptake of IgG-Antigen Complexes, The Journal of Biological Chemistry, vol. 255, No. 14, Jul. 25, 1980, pp. 6820-6825.
Harris et al., Tibtech 11:42, 1993, Therapeutic . . . Age.
Hird et al., Cancer & Genes, 1990, Immunotherapy . . . Antibodies.
Wileman et al., 1986, J. Pharm. Pharmacol., 38: 264, Soluble . . . Reactivity Sigma Catalog, 1989, p. 104.
Kindt et al., The Antibody Enigma, pp. 71-72, 1984.
Kuchler et al., Eur. J. Cell. Bio., 1990, 52(1):87-97.
Galli et al., J. Nucl. Med. Allied Sci., 1988, 32(2):110.
Morrell et al., J. Biol. Chem., 1971, 246(5):1461.
Mattes, 1987, JNCI, 79(4):855.
Vansteenkiste et al., J. Controlled Release, 1991, 16:91.
Sharma, S.K. et al., "Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model." Br. J. Cancer (1990), 61, 659-662.
Goodwin et al., J. Nucl. Med., vol. 33, No. 11, pp. 2006-2013, "Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake".
Morell et al., J. Biol. Chem., vol. 246, No. 1, p. 1461-1467, "The Role of Sialic Acid in Determining the Survival of Glycoproteins in the Circulation".
Tolleshaug, Int. J. Biochem., vol. 13, pp. 45-51, "Binding and Internalization of Asialo-glycoproteins by Isolated Rat Hepatocytes".
Wall et al., Cell, vol. 21, pp. 79-93, "The Galactose-Specific Recognition System of Mammalian Liver: The Route of Ligand Internalization in Rat Hepatocytes".
Galli et al., J. Nucl. Med., vol. 32, No. 2, pp. 110-116, "A Radio-pharmaceutical for the Study of the Liver:.sup.99m Tc-DTPA-Asialo-Orosomucoid I: Radiochemical and Animal Distribution Studies".
Van Der Sluijs et al., Hepatology, vol. 6, No. 4, pp. 723-728, 1986, "Drug Targeting to the liver with lactosylated albumins: does the glycoprotein target the drug or is the drug targeting the glycoprotein?".
Virzi et al., Nucl. Med. Biol., vol. 18, No. 7, pp. 719-726, 1991, "New Indium-111 Labeled Biotin Derivates for Improved Immunortargeting".
R. T. Lee et al, Glycoconjugate, "Preparation of Cluster Glycosides of N-Acetylgalactosamine That Have Subnanomolar Binding Constants Towards the Mammalian Hepatic Gal/GaINAc-specific Receptor", vol. 4, (1987), pp. 317-328.
R. T. Lee et al, Biochemistry, "New Synthetic Cluster Ligands for Galactose/N-Acetylgalactosamine-Specific Lectin of Mammalian Liver", vol. 23, (1984), pp. 4255-4261.
J. R. Merwin et al, Bioconjugate Chem., "Targeted Delivery of DNA Using YEE(GaINAcAH).sub.3, a Synthetic Glycopeptide Ligand for the Asialoglycoprotein Receptor", vol. 5 (1994), pp. 612-620.
M. A. Findeis, Int. J. Peptide Protein Res., "Stepwise synthesis of a GaINAc-containing cluster glycoside ligand of the asialoglycoprotein receptor", vol. 43, (1994), pp. 477-485.
T. D. McKee et al, Bioconjugate Chem., "Preparation of Asialoorosomucoid-Polylysine Conjugates", vol. 5, (1994), pp. 306-311.
E. A. L. Biessen et al, J. Med. Chem., "Synthesis of Cluster Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor", vol. 83 No. 9, (1995), pp. 1538-1546.
Sheldon et al., Appl. Radiat. Isot., vol. 43, pp. 1399-1402, "Targeting of Covalent Monoclonal Antibody-Streptavidin Conjugates".
Sharon et al., Scientific American, vol. 268, No. 1, pp. 82-89, "Carbohydrates in Cell Recognition".
Goodwin, J. Nucl. Med., vol. 33, No. 10, pp. 1816-1818, "New Methods for Localizing Infection: A role for Avidn-Biotin?".

Affiliated with

Also associated with

Rating

Pretargeting methods and compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pretargeting methods and compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pretargeting methods and compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1708152